P917: HOW COMORBID ARE OUR MYELOMA PATIENTS AND HOW MANY MAKE IT TO THE SECOND-LINE TREATMENT: REAL-WORLD DATA OF 251 MYELOMA PATIENTS TREATED IN THE HEMATOLOGICAL NETWORK OF THE OEGK

• F. Keil,
• P. Attalla

Affiliations

F. Keil

1 3rd Medical Department for Hematology and Oncology, Hanusch hospital, Vienna, Austria

P. Attalla

1 3rd Medical Department for Hematology and Oncology, Hanusch hospital, Vienna, Austria